Skip to content

electroCore, Inc. ECOR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Neuropace, Inc. logo
Neuropace, Inc.NPCE
$10K-97.4%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$148K
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$2.84M-3.6%
Avanos Medical logo
Avanos MedicalAVNS
$400K0.0%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$3.3M
Neuronetics logo
NeuroneticsSTIM
$20.7M+8,279,900%

Other financials

Income statement

See full
Revenue$9.6M+42.6%
Gross profit$8.4M+46.6%
Operating income-$5.3M-39.1%
Net income-$5.3M-36.7%
EPS (diluted)-$0.59-25.5%

Balance sheet

See full
Cash & equivalents$4.9M+20.5%
Total debt$9.5M+127%
Total equity-$5.7M-230%
Total assets$15.5M-3.5%

Cash flow

See full
Operating cash flow-$3.0M+30.9%
CapEx$2.0K-94.6%
Free cash flow-$3.0M+31.5%

Valuation

See full
Market cap$71.67M+81.6%
Enterprise value$76.31M+90.2%
P/S2.1×+0.6×

Profitability

See full
Gross margin87.2%+2.0pp
Operating margin-42%-3.3pp
Net margin-44.1%-2.0pp
FCF margin-19.7%

Returns & leverage

See full
Return on equity-210.6%+125pp
Debt / equity3.8×+3.5×
Current ratio-0.5×

Where this comes from

Reported directly by electroCore, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: electroCore, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about electroCore, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is electroCore, Inc.'s stock issuance proceeds?
electroCore, Inc. (ECOR) reported stock issuance proceeds of $7K in Q1 2026.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.